Overview
Bayer supplies prescription and OTC medicines, crop protection and consumer-health products in Poland under Bayer and Berocca. It serves pharmacies, agriculture and medical distributors.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-10-31. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 23, 2025 | Commercial Companies Code notice | |
| Oct 31, 2024 | Merger registered |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
358 tenders recorded as contractor: 74 national ($5,090,417) and 284 EU ($913,829,395).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 2, 2026 | Dostawa leków programowych, onkologicznych, płynów infuzyjnych, erytropoetyny oraz kontrastów | —— | Wojewódzki Szpital Specjalistyczny Nr 4 w Bytomiu | |
| Sep 30, 2026 | Sterylne wyroby medyczne jednorazowego użytku | —— | Wojewódzki Specjalistyczny Szpital Dziecięcy Im. Prof. Dr Stanisława Popowskiego w Olsztynie | |
| Sep 29, 2026 | Dostawa materiałów radioizotopowych | —— | Mazowiecki Szpital Wojewódzki Im. Św. Jana Pawła II w Siedlcach sp. z o.o. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bayer Global Investments B.v. | 151,340 | $40,880,605.08 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Simon Johannes Britsch (47)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Lyndsay Sullivan (48)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DOZ Directsp. k. | $767,165,903.98 | doz.pl | ||
| BASF Polskasp. z o.o. | $742,117,528.88 | basf.pl | ||
| L`Oreal Polskasp. z o.o. | $610,607,471.07 | loreal.pl | ||
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| Brenntag Polskasp. z o.o. | $548,791,874.18 | brenntag.pl | ||
| HurtapS.A. | $480,276,955.20 | hurtap.com.pl | ||
| Centrala Farmaceutyczna CefarmS.A. | $457,052,669.59 | cefarm.com.pl | ||
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.pl | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| YARA Polandsp. z o.o. | $296,073,539.39 | yara.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-11-29 | Share capital change (151,339,000.00 PLN → 151,340,000.00 PLN) | |
| 2009-09-11 | Share capital change (71,339,000.00 PLN → 151,339,000.00 PLN) | |
| 2001-08-14 | Entered in the register |
FAQ
Last updated: 2026-07-23